Matches in Nanopublications for { ?s ?p "[In conclusion, our results demonstrate the ability of hydralazine and valproate to increase the NK activity against epithelial cancer cell lines and suggest that these drugs could reduce the levels of soluble MICA and MICB helping in avoiding tumor-induced suppression of NK cytotoxicity against the tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_assertion description "[In conclusion, our results demonstrate the ability of hydralazine and valproate to increase the NK activity against epithelial cancer cell lines and suggest that these drugs could reduce the levels of soluble MICA and MICB helping in avoiding tumor-induced suppression of NK cytotoxicity against the tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_provenance.
- NP556288.RA3OX7ntHcfatzY5YBOnD42EARAGESgQuPcgXLGn--_u0130_assertion description "[In conclusion, our results demonstrate the ability of hydralazine and valproate to increase the NK activity against epithelial cancer cell lines and suggest that these drugs could reduce the levels of soluble MICA and MICB helping in avoiding tumor-induced suppression of NK cytotoxicity against the tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556288.RA3OX7ntHcfatzY5YBOnD42EARAGESgQuPcgXLGn--_u0130_provenance.
- NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_assertion description "[In conclusion, our results demonstrate the ability of hydralazine and valproate to increase the NK activity against epithelial cancer cell lines and suggest that these drugs could reduce the levels of soluble MICA and MICB helping in avoiding tumor-induced suppression of NK cytotoxicity against the tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_provenance.
- NP556247.RAqcb-riMStMp29ddPLnWE8aErX2vd2Gdq25GxTeLfZtQ130_assertion description "[In conclusion, our results demonstrate the ability of hydralazine and valproate to increase the NK activity against epithelial cancer cell lines and suggest that these drugs could reduce the levels of soluble MICA and MICB helping in avoiding tumor-induced suppression of NK cytotoxicity against the tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556247.RAqcb-riMStMp29ddPLnWE8aErX2vd2Gdq25GxTeLfZtQ130_provenance.